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Abstract
Monoclonal antibodies that bind to human leukocyte antigen (HLA) are useful tools for HLA-
typing, tracking donor-recipient chimerisms after bone marrow transplants, and characteriz-
ing specific major histocompatibility complexes (MHC) on cell surfaces. Unfortunately,
equivalent reagents are not available for rhesus macaques, which are commonly used ani-
mal as models in organ transplant and infectious disease research. To address this defi-
ciency, we isolated an antibody that recognizes the common Indian rhesus macaque MHC
class I molecule, Mamu-A1*001. We induced Mamu-A1*001-binding antibodies by alloim-
munizing a female Mamu-A1*001-negative rhesus macaque with peripheral blood mononu-
clear cells (PBMC) from a male Mamu-A1*001-positive donor. A Fab phage display library
was constructed with PBMC from the alloimmunized macaque and panned to isolate an
antibody that binds to Mamu-A1*001 but not to other common rhesus macaque MHC class
I molecules. The isolated antibody distinguishes PBMC from Mamu-A1*001-positive and
-negative macaques. Additionally, the Mamu-A1*001-specific antibody binds the cynomol-
gus macaque MHC class I ortholog Mafa-A1*001:01 but not variants Mafa-A1*001:02/03,
indicating a high degree of binding specificity. The Mamu-A1*001-specific antibody will be
useful for identifying Mamu-A1*001-positive rhesus macaques, for detecting Mamu-
A1*001-positive cells in populations of Mamu-A1*001-negative cells, and for examining dis-
ease processes that alter expression of Mamu-A1*001 on cell surfaces. Moreover, the
alloimmunization process we describe will be useful for isolating additional MHC allomorph-
specific monoclonal antibodies or antibodies against other polymorphic host proteins which
are difficult to isolate with traditional technologies.
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Introduction
Major histocompatibility complex (MHC) class I and II molecules are present in all vertebrate
animals and serve an important function in adaptive cellular immune responses. They bind
pathogen-derived peptides and present them on cell surfaces to CD8+ and CD4+ T cells
respectively. The genes encoding MHC molecules are highly polymorphic and encode amino
acid differences that affect peptide binding and T-cell recognition [1]. These subtle differences
among MHC molecules can induce potent immune responses when individuals are exposed to
allogeneic cells. For example, anti-human leukocyte antigen (HLA) antibodies naturally
develop following exposure to fetal cells during pregnancy [2, 3], to organ transplants [4], and
to multiple blood transfusions [5]. The anti-HLA antibodies raised in these individuals recog-
nize epitopes specific to a few individual or small subsets of MHC allotypes [6, 7]. This is due
to the elimination of pan-reactive B-cell receptors recognizing “self” epitopes shared by all
MHC molecules during B-cell education [8]. Until recently, HLA phenotyping was commonly
performed using serum from multiparous women who naturally developed anti-paternal
MHC antibodies during the course of pregnancy [9]. However, the multi-specificity, low-titer,
and restricted availability of defined serum limited the usefulness of anti-HLA antisera for
other applications.
Advances in immortalizing human B cells and the development of phage-display technolo-
gies allowed for the isolation of anti-HLA monocolonal antibodies from allosensitized individ-
uals [10, 11]. The anti-HLA antibodies have proven to be valuable reagents for investigating
MHC molecules themselves and their role in disease processes. For example, the HLA-A2-spe-
cific antibody has been used to purify HLA-A2 molecules for the purpose of characterizing
HLA-A2 bound peptides [12, 13], for confirming HLA-A2 restriction of epitope-specific CD8
+ T-cell responses [14, 15], and for examining HLA-A2 cell surface downregulation by the
HIV Nef protein [16, 17]. Additionally, anti-HLA antibodies are used to monitor donor and
recipient cell chimerism after hematopoietic stem cell transplants [18, 19]. These studies dem-
onstrate the utility of MHC allomorph-specific monoclonal antibodies in different areas of
medical research.
Rhesus macaques are important animal models for organ transplantion and infectious dis-
ease research [20–24]. Understanding the role MHC molecules play in these models may lead
to improved clinical treatment in humans. The genetic organization of the MHC is highly con-
served between macaques and humans [25] and our understanding of macaque MHC genetics
has significantly expanded over the past 15 years [25–28]. These advances have facilitated the
use of MHC-defined macaques in pre-clinical studies. However, monoclonal antibodies spe-
cific for macaque MHC have not been available for MHC screening, for in vitro assays or for
measuring chimerism.
The study described herein addresses this deficiency. We aimed to isolate a monoclonal
antibody specific for the rhesus macaque MHC class I molecule Mamu-A1001. We took
advantage of the fact that multiparous females often make MHC antibodies directed against
non-framework epitopes after multiple pregnancies and would likely be sensitized to our
MHC allomorph of interest. We stimulated the production of Mamu-A1001-binding anti-
bodies in a multiparous Mamu-A1001-negative macaque by alloimmunizing her with PBMC
from a Mamu-A1001-positive donor. Mamu-A1001-binding antibodies were clearly detect-
able in the serum one week after the first immunization. To isolate a monoclonal antibody, we
constructed a Fab phage display library using lymphocytes isolated from the alloimmunized
animal and panned the library for Mamu-A1001-specific antibodies. An antibody was iso-
lated that binds Mamu-A1001 but not other common Mamu-A or -B allomorphs. Addition-
ally, the anti-Mamu-A1001 antibody bound to the cynomolgus macaque MHC class I
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ortholog Mafa-A1001:01 but not variants Mafa-A1001:02/03. This antibody has potential
utility in screening rhesus or cynomolgus macaques for Mamu-A1001 or Mafa-A1001:01
respectively, tracking chimerism after hematopoietic stem cell transplants, or investigating dis-
ease processes in these animal models. The approach we describe here may also be effective in
isolating monoclonal antibodies against other polymporphic proteins.
Materials and methods
Ethics statement and animal care
Rhesus macaques (Macaca mulatta) used in this study were cared for by the staff at the Wiscon-
sin National Primate Research Center according to regulations and guidelines of the University
of Wisconsin Institutional Animal Care and Use Committee, which approved this study (proto-
col g00695) in accordance with recommendations of the Weatherall report and according to
the principles described in the National Research Council’s Guide for the Care and Use of Labo-
ratory Animals. Per Animal Wellfare Approved regulations, all animals were housed in enclo-
sures with at least 4.3, 6.0, or 8.0 sq. ft. of floor space, measuring 30, 32, or 36 inches high, and
containing a tubular PVC or stainless steel perch. Each individual enclosure was equipped with
a horizontal or vertical sliding door, an automatic water lixit, and a stainless-steel feed hopper.
All animals were fed using a nutritional plan based on recommendations published by the
National Research Council. Twice daily the macaques on the described study were fed a fixed
formula, extruded dry diet (2050 Teklad Global 20% Protein Primate Diet) with adequate car-
bohydrate, energy, fat, fiber (10%), mineral, protein, and vitamin content. Feeding strategies
were individually tailored to the age and physical condition of the experimental subjects. Dry
diets were supplemented with fruits, vegetables, and other edible objects (e.g., nuts, cereals, seed
mixtures, yogurt, peanut butter, popcorn, marshmallows, etc.) to provide variety to the diet and
to inspire species-specific behaviors such as foraging. To further promote psychological well-
being, animals were provided with food enrichment, human-to-monkey interaction, structural
enrichment, and manipulanda. Environmental enrichment objects were selected to minimize
chances of pathogen transmission from one animal to another and from animals to care staff.
While on study, all animals were evaluated by trained animal care staff at least twice each day
for signs of pain, distress, and illness by observing appetite, stool quality, activity level, and
physical condition. Animals abnormally presenting for any of these clinical parameters were
provided appropriate care by attending veterinarians. Prior to all experimental procedures,
animals were sedated using ketamine anesthesia, which was reversed at the conclusion of a pro-
cedure using atipamezole. Animals were monitored regularly until fully recovered from anes-
thesia. Animals were returned to the colony at the conclusion of this study.
MHC genotyping of macaques
MHC class I sequences were determined by deep sequencing as previously described [29].
Briefly, genomic DNAs isolated from frozen whole blood samples were used as templates for
PCR with a pair of primers that bind highly conserved sequences flanking the highly polymor-
phic peptide binding domain encoded by exon 2 of class I loci. After cleanup and pooling,
these amplicons were sequenced on an Illumina MiSeq instrument and the resulting sequence
reads were mapped against a custom database of rhesus macaque class I sequences.
Alloimmunizations
We adapted an immunization regimen used to treat women for recurrent spontaneous abor-
tions to generate MHC allomorph-binding antibodies in macaques [30, 31]. A Mamu-
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A1001-negative rhesus macaque received three immunizations three weeks apart with PBMC
freshly isolated from a Mamu-A1001-positive rhesus macaque. Each immunization consisted
of up to 40 million PBMC suspended in PBS containing 15U/ml heparin divided as follows: ¼
of the cells administered intravenously and the remaining of the cells divided equally between
three intradermal sites on the forearm. Blood and serum was collected one-week after each
immunization to construct the phage display library and screen for MHC-binding antibodies.
Screening sera for Mamu-A1*001-binding antibodies
MHC gene transferents, a human MHC class I-deficient, Epstein-Barr virus-transformed B
lymphoblastoid cell line (721.221) transfected with rhesus macaque MHC class I molecules
[32, 33], and the parental MHC-class I null cell line (721.221) were incubated for 1 hour at
37˚C with 20 μl of 1:20 diluted serum. The mouse anti-human MHC class I antibody (clone
W6/32; Fisher Scientific) and non-specific mouse IgG1 (BD Biosciences) were included as pos-
itive and negative controls, respectively. Cell-bound antibodies were detected with anti-
macaque IgG FITC (1B3; NIH Nonhuman Primate Reagent Resource) or goat anti-mouse Ig
FITC (polyclonal; BD Biosciences) by incubating antibody-exposed cells for 30 minutes at
room temperature. The cells were then fixed with 2% paraformaldehyde and stored at 4˚C
until being acquired on a LSR II flow cytometer (Becton Dickinson). The data was analyzed
using FlowJo software (Tree Star).
Construction of the Fab library
The Fab library was constructed as previously described in Phage Display: A Laboratory Man-
ual by Barbas et al [34] using the pComb3X system, rhesus macaque-specific primers and con-
ditions detailed in Kuwata et al [35]. The pComb3XSS phagemid was obtained from the Office
of Technology Development at the Scripps Research Institute in La Jolla, CA. Briefly, total
RNA was prepared from PBMC isolated 1–2 weeks post-immunization using an RNeasy Mini
Kit (Qiagen) and used for first-strand cDNA synthesis with oligo(dT)20 primers and Super-
Script III Reverse Transcriptase (Invitrogen) per the manufacturer’s instructions. Three
rounds of overlap extension PCR were performed to amplify and join constant and variable
regions of the immunoglobulin heavy- and light (κ and λ) chains into Fab fragments. All PCR
reactions were carried out with Platinum Taq DNA polymerase High Fidelity (Thermo Fisher
Scientific) and purified from agarose gels using the QIAquick Gel Extraction Kit (Qiagen). To
complete the phage library, the Fab DNA fragments were ligated overnight into sfiI- digested
(New England Biolabs) pComb3X and transformed into E. coli XL1-Blue (Stratagene) by elec-
troporation. Transformed bacteria were inoculated into SOC medium (Thermo Fisher Scien-
tific), incubated for 1 hour at 37˚C, and grown overnight at 37˚C on “Circlegrow” (MP
Biomedicals) agar plates containing 100μg/ml ampicillin. Transformed cultures were grown at
37˚C in 2xTY medium containing 100μg/ml ampicillin and 1% glucose (2xTY + 1% glu) until
the OD600 reached 4. 2x10
11 KM13 helper phages were added and the culture was incubated
for 30 minutes at 37˚C. Pelleted bacteria were suspended in 2xTY medium containing 100 μg/
ml ampicillin, 50μg/ml kanamycin, plus 0.1% glucose and grown overnight at 30˚C. Library
phages were precipitated from the culture medium with 20% (w/v) polyethylene glycol (PEG)
8000/ 2.5M NaCl. The size of the library was estimated by infecting E. coli with serially diluted
phage and counting the number of colony-forming units.
Panning for Mamu-A1*001-binding phages
The first four rounds of panning were performed by mixing 8μg of biotinylated Mamu-
A1001 monomer acquired from either the NIH or Wisconsin National Primate Research
Isolation of a monoclonal antibody to the rhesus macaque MHC class I allomorph Mamu-A1*001
PLOS ONE | https://doi.org/10.1371/journal.pone.0179039 July 18, 2017 4 / 18
Center Tetramer Cores with 1010 phage and incubating for 1 hour at room temperature. The
MHC-binding phages were captured by adding streptavidin-coupled magnetic beads (Invitro-
gen) suspended in “PBS Tween” containing 4% fetal bovine serum (FBS) and 1% Tween 20
and incubated for 30 minutes at room temperature. Phage-MHC-streptavidin bead complexes
were washed ten times with PBS Tween by applying the tube containing the suspended com-
plexes to an external magnet (Invitrogen) and discarding the unretained beads in the superna-
tant. MHC-binding phages were eluted from the bead complexes by incubating with 0.1M
glycine at room temperature for 15 minutes. The mixture was magnet precipitated and neu-
tralized with 1M Tris-HCL (pH = 7.4). The released phages were amplified in E.coli TG1
(Source BioScience). A negative selection to remove pan-MHC binding phages was performed
prior to the fourth round of panning by incubating with biotinylated Mamu-A1002 mono-
mers. The supernatant from this step was used to complete the panning process with Mamu-
A1001 monomers.
Two additional rounds of panning were performed with MHC class I transferents. Prior to
both rounds, negative selection was performed by incubating phages for 30 minutes at room
temperature with transferents expressing Mamu-B008. The cells were then pelleted and the
supernatant collected to pan with Mamu-A1001 transferents. The mixture of phages and cells
were incubated for 30 minutes at room temperature. The cells were washed ten times with
FACS buffer. Cell-bound phage was eluted using 100mM triethylamine and neutralized with
1M Tris-HCL.
ELISA to detect Mamu-A1*001-specific phages
MHC-coated 96-well plates were prepared by incubating pre-blocked streptavidin-coated
plates (Pierce) with biotinylated rhesus macaque MHC class I monomers (20 μg/ml) and incu-
bating for one hour at room temperature. The wells were then washed three times with PBS
containing 2% Tween 20 (T-PBS).
E.coli TG1 was infected with phages, grown overnight at 37˚C on TYE plates containing
100 μg/ml ampicillin and 1% glucose. Isolated bacterial colonies were grown overnight in
96-deep-well plates (Thermo Fisher Scientific) in 2xTY + 1% glu at 37˚C while shaking. 10μl
from each well were inoculated into a well on a second 96-deep-well plate containing 2xTY
+1% glu and incubated for 3 hours at 37˚C. 100μl of 2xTY+1% glu medium containing 109
KM13 helper phage was added to each well and incubated for one hour at 37˚C. The bacteria
were resuspended in 200μl of 2xTY containing 100μg/ml ampicillin, 0.1% glucose, and 50 μg/
ml kanamycin and were grown overnight at 30˚C. After pelleting, 100μl of each phage-con-
taining supernatant was added to the prepared MHC-coated ELISA plates and incubated for
90 minutes at room temperature. The mouse pan-MHC class I-binding antibody W6/32 was
used as a positive control and medium alone was used as a negative control. The plate was
washed three times with T-PBS. Bound phages were detected with a 1:5,000 dilution of horse-
radish peroxidase (HRP)-conjugated anti-M13 antibody (GE Healthcare Life Sciences catalog
# 27-9421-01) in PBS containing 4% bovine serum albumin and incubated for 40 minutes at
room temperature. The mouse anti-MHC antibody was detected with goat anti-mouse
IgG-HRP (Thermo Fisher Scientific catalog # AHI0704). The plates were washed three times
with T-PBS. The colorimetric substrate TMB (Thermo Fisher Scientific) was added to each
well and incubated at room temperature for 2–30 minutes per manufacturer’s instructions.
The reaction was stopped with 50μl of 0.18 M sulphuric acid and read on a GloMax Multi
plate reader (Promega) at an OD450.
Isolation of a monoclonal antibody to the rhesus macaque MHC class I allomorph Mamu-A1*001
PLOS ONE | https://doi.org/10.1371/journal.pone.0179039 July 18, 2017 5 / 18
Anti-Mamu-A1*001 Fab production
E.coli XL1-Blue was infected with a Mamu-A1001-binding phage clone by inoculating an
individual bacterial colony into 10ml of Super broth (10g MOPS (3-[N-morpholino]-propane-
sulfonic acid), 30g tryptone, 20g yeast extract, 1L distilled water) containing 100ug/ml ampicil-
lin plus 10ug/ml tetracycline and incubating at 37˚C overnight. The overnight culture was
added to 1L of Super broth and incubated at 37˚C. After 8 hours, Fab production was induced
by adding 10ml of 0.1M isopropyl β-D-1-thiogalactopyranoside (IPTG; Sigma-Aldrich) and
incubated overnight at 37˚C. The bacteria were pelleted and suspended in 20ml of PBS con-
taining 200μM phenylmethanesulfonyl fluoride (PMSF; Sigma-Aldrich). The bacterial suspen-
sion was sonicated using a Branson Sonifier 250 in an ice-water bath for 180 seconds, with
50% duty cycle, and output control set to 5. The cellular debris was removed by centrifugation.
Detection of MHC-binding phage or Fab antibody fragments by flow
cytometry
2-5x105 rhesus or cynomolgus macaque PBMC or MHC transferents were incubated for 30
minutes at 4˚C with 50μl of phage-containing supernatant or Fab-containing bacterial lysate.
The MHC class I-specfic antibody W6/32 was used as a positive control and non-specific
mouse IgG1 was used as a negative control. The cells were washed twice with FACS buffer
(PBS + 2% FBS). Bound Fab fragments fused to a HA tag were detected with high affinity anti-
HA-FITC (3F10; Roche Diagnostics) or bound phages were detected with anti-M13-PE
(RL-PH2; Santa Cruz Biotech). The control antibodies were detected by incubation with goat
anti-mouse Ig FITC or PE (BD Biosciences) for 50 minutes at room temperature. The cells
were washed twice with FACS buffer, fixed with 2% paraformaldehyde (PFA) and stored at
4˚C until being acquired on a LSR II flow cytometer. The data was analyzed using FlowJo
software.
Construction of a full-length anti-Mamu-A1*001 IgG molecule
The isolated anti-Mamu-A1001 Fab antibody gene was sequenced and the heavy and light
chain variable regions were cloned into pCOXW expression vector containing rhesus IgG1
and rhesus kappa constant regions. The full-length rhesus IgG1κ antibody was expressed by
transient transfection of 293T cells using Lipofectamine 2000. Antibody was purified using
HiTrap Protein A HP resin and then conjugated to R-phycoerythrin using thiol maleimide
coupling.
Screening whole blood to identify Mamu-A1*001 positive macaques
100μl of fresh or frozen whole blood from rhesus macaques were placed into cluster tubes
(Thermo Fisher Scientific) and incubated with either the anti-Mamu-A1001 Fab-containing
bacterial lysate, MHC class I-specific antibody W6/32 (positive control), or non-specific
mouse IgG1 (negative control) for 30 minutes at room temperature. The red blood cells were
lysed by incubating with BD FACS Lyse solution (BD Biosciences) for 10 minutes at room
temperature. The cells were washed twice with FACS buffer. Cell-bound anti-Mamu-A1001
Fab fragments were detected with anti-HA FITC and control antibodies with goat anti-mouse
Ig FITC secondary antibodies. After a 30-minute incubation at room temperature the cells
were washed twice with FACS buffer, fixed with 2% paraformaldehyde (PFA) and stored at
4˚C until being acquired on a LSR II flow cytometer. The data was analyzed using FlowJo
software.
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Results
Alloimmunization of a multiparous female rhesus macaque
We endeavored to generate and isolate a monoclonal antibody against the rhesus macaque
MHC class I molecule Mamu-A1001. This molecule is expressed by a high frequency of
Indian-origin rhesus macaques at primate colonies in the United States [25] and Mamu-
A1001-positive macaques are commonly used in Simian Immunodeficiency Virus (SIV)
infection studies. Consequently, SIV-derived CD8+ T-cell epitopes restricted by Mamu-
A1001 have been well characterized [32, 36, 37]. This has led to the development of Mamu-
A1001-specific reagents for tracking antiviral CD8+ T-cell responses including Mamu-
A1001 monomers [32, 38–40]. The availability of these reagents made Mamu-A1001 an
attractive target for isolating a rhesus macaque allomorph-specific monoclonal antibody.
Multiparous female animals often develop alloreactive antibody responses to non-self-epi-
topes that distinguish individual MHC allomorphs rather than framework epitopes present on
all MHC molecules [10]. To stimulate production of Mamu-A1001-binding antibodies, we
alloimmunized a Mamu-A1001-negative macaque mother of multiple Mamu-
A1001-positive offspring with a lymphocyte immunotherapy regimen previously employed
to treat humans for recurrent spontaneous abortions (Fig 1) [31]. In the human clinical trials,
the alloimmunizations were well-tolerated and readily induced anti-MHC antibodies [30, 41].
The donor and recipient macaques were also mismatched at their MHC B loci haplotypes
(Table 1).
We screened for MHC-binding antibodies in the serum of the alloimmunized macaque
using MHC “transferents”, an immortalized human B-cell line expressing single MHC class I
molecules in isolation [33]. Mamu-A1001-binding antibodies were detected in the serum one
week after the first PBMC alloimmunization. We observed a distinct shift in the histogram of
the Mamu-A1001 transferent with serum from the alloimmunized female in comparison to
incubation with pre-immunization serum, serum incubated with non-Mamu-A1001 transfer-
ents, or the parental MHC class I-null 721.221 cell line (Fig 2). The Mamu-A1001-binding
Fig 1. Overview of the antibody selection process. A) PBMC from a Mamu-A1*001 positive macaque was used to
alloimmunize a Mamu-A1*001 negative macaque to induce Mamu-A1*001-binding antibodies. B) Timeline for the
immunizations and blood draws for the alloimmunized animal. C) The panning process to isolate the Mamu-
A1*001-binding antibody was initiated by amplifying immunoglobulin genes from the alloimmunized macaque and
inserting into the phagemid pCOMB3X. The resulting phage library was screened with biotinylated MHC molecules bound
to streptavidin-coated magnetic beads and applied to a magnet to wash away unbound phage. Bound phage was eluted
and amplified in E.coli for new rounds of selection.
https://doi.org/10.1371/journal.pone.0179039.g001
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antibody responses were durable as they were detected in the serum two months after the third
alloimmunization. Although the MHC transferent panel did not cover all potential rhesus
macaque MHC molecules the results from the serum screen we performed indicated that the
alloimmunized animal contained B cells that specifically recognized Mamu-A1001.
Construction and panning of a Fab phage display library
Isolating monoclonal antibodies from primates using conventional hybridoma techniques can
be challenging due to the difficulty in isolating sufficient numbers of B cells from peripheral
blood and the low efficiency of B-cell/myeloma fusions [42]. Therefore, we attempted the alter-
native of constructing a fragment antigen binding (Fab) phage display library from the PBMC
of the alloimmunized macaque to isolate a Mamu-A1001-specific antibody. Rhesus macaque-
specific primers were used to amplify the variable regions of the immunoglobulin genes as pre-
viously described by Kuwata et al [35]. The amplified Fab antibody fragments were cloned into
the pComb3X phage display system [34]. The diversity of the Fab library was estimated to be
2x1012 different antibody molecules.
Biotinylated MHC monomers were used to initiate panning the phage library for antibody
fragments that specifically bound to Mamu-A1001. The random combinations of immuno-
globulin variable fragments created during construction of the phage library had the potential
to generate Fabs recognizing determinants common to all or a large subset of MHC molecules.
To remove pan-reactive Fabs we performed negative selections with Mamu-A1002
Table 1. MHC haplotypes of donor and recipient rhesus macaques.
Animals Haplotype A1 Haplotype A2 Haplotype B1 Haplotype B2
Alloimmunized female macaque A004 A023 B001 B017c
PBMC donor macaque A001 A001 B012a B024a
https://doi.org/10.1371/journal.pone.0179039.t001
Fig 2. Screening serum of the alloimmunized macaque for Mamu-A1*001-binding antibodies. MHC class I transferents expressing
only either Mamu-A1*001 or Mamu-A1*002 and the parental MHC class I-null cell line (721.221) were incubated with (A) pre-, (B) 7-days
post-, and (C) 2-months post-immunization serum from the alloimmunized macaque. Cell-bound serum antibodies were detected with FITC-
labeled anti-macaque IgG FITC.
https://doi.org/10.1371/journal.pone.0179039.g002
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monomers to adsorb phages binding shared MHC epitopes or biotin. After each round of pan-
ning we observed increased numbers of transduced E.coli, indicating enrichment for phages
that bound to Mamu-A1001. We isolated 96 phage clones after the fourth round of panning
and tested their specificity against Mamu-A1001. Mamu-B008 monomers were used as a
negative control for non-specific binding. Twelve of the 96 clones bound to Mamu-A1001
but, disappointingly, also bound to Mamu-B008, indicating that negative selection with
Mamu-A1002 had not removed all phages reactive with other MHC allomorphs. Using the
phages from the fourth round of panning, two additional rounds of cell-based panning with
Mamu-A1001 and Mamu-B008 transferents were performed. The phages were pre-incu-
bated with Mamu-B008 transferents to remove unwanted phage prior to positively selecting
for those binding Mamu-A1001.
After the sixth round of library panning, 96 new phages were cloned and tested for their
ability to discriminated between Mamu-A1001 and -B008 in a flow cytometry-based assay.
Six of the phage clones bound to Mamu-A1001 but not Mamu-B008 (Fig 3), signaling that
the last two rounds of panning eliminated cross reactive clones and enriched for those
specific for Mamu-A1001. Additionally, this suggested that we had isolated phage clones that
could, at a minimum, distinguish Mamu-A1001 from Mamu-A1002 and Mamu-B008.
However, further analysis was necessary to fully characterize the MHC allomorph-binding
specificity.
Screening Mamu-A1*001-binding Fabs against whole cells
In order to be a useful reagent, the Mamu-A1001-binding antibody needs to distinguish
Mamu-A1001 from a broad variety of rhesus macaque MHC class I molecules. Although we
were encouraged by the specificity of the phages binding to Mamu-A1001 but not Mamu-
B008 transferents, the intensity of the staining was low in comparison to the anti-MHC
monoclonal antibody positive control (data not shown). In order to gain better separation
between positive and negative cell populations, we produced in bulk the Fab molecule from
phage clone number 12 that had the strongest Mamu-A1001-binding characteristics. There-
fore, hereafter we refer to this Fab fragment as P12. P12 was produced in the periplasm of
Fig 3. Testing the specificity of Mamu-A1*001-panned phages with MHC class I transferents. Mamu-
A1*001-panned phage clones were incubated with the MHC class I-null cell line 721.221 and with MHC class
I transferents expressing Mamu-A1*001 or Mamu-B*008. Cell-bound phages were detected with PE-labeled
anti-M13 phage antibody. Representative data from the phage clones that did (A) or did not (B) preferentially
bind to Mamu-A1*001 transferents are shown.
https://doi.org/10.1371/journal.pone.0179039.g003
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transformed E.coli and collected by lysing the bacteria. As part of the pComb3X vector system,
P12 was fused to human influenza hemagglutinin (HA) tag for detection with secondary
antibodies.
Initial screening of P12 was performed with a panel of eleven MHC transferents expressing
just one of five Mamu-A or six -B allomorphs. Fig 4 shows that P12 substantially bound to the
Mamu-A1001 transferent, but negligibly to other MHC transferents. This indicated for the
first time that the isolated Fab fragment was likely specific for Mamu-A1001 and could distin-
guish between Mamu-A1001-positive and -negative cell populations by flow cytometry.
Encouraged by the apparent specificity and enhanced binding of P12 molecules to
Mamu-A1001 we tested them against a panel of MHC-diverse Indian rhesus macaque
PBMC. We identified nine Mamu-A1001-negative macaques expressing common MHC-A
and -B haplotypes. These cells provided a more rigorous test of P12 specificity since they
expressed combinations of diverse MHC molecules and not just single MHC class I allo-
morphs expressed in isolation on MHC transferents. PBMC isolated from the nine Mamu-
A1001 negative macaques, along with PBMC from three Mamu-A1001-positive macaques,
were stained with P12 (Fig 5). The staining clearly demonstrated that the Fab only bound
PBMC from animals expressing Mamu-A1001 and not any of the MHC present on the 12
MHC-A or 14 –B haplotypes expressed by the Mamu-A1001-negative macaques. Although
it is formally possible that P12 cross-reacts with relatively rare MHC allomorphs present in
captive Indian rhesus macaques, our results suggest that P12 can distinguish between cells
expressing Mamu-A1001 and cells expressing any of many other common Indian rhesus
Fig 4. Testing the specificity of P12 against a panel of MHC class I transferents. P12 was incubated with MHC class I
transferents expressing common Mamu-A and Mamu-B alleles (blue traces) and the MHC class I-null cell line 721.221 (red traces).
Cell-bound Fab fragments were detected with FITC-labeled anti-HA antibody.
https://doi.org/10.1371/journal.pone.0179039.g004
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macaque MHC class I allomorphs. Of note, we did not test P12 against cells from Chinese-
origin rhesus macaques. Therefore, we do not know whether P12 will bind to Mamu-A1001
variants expressed by Chinese rhesus macaques or will bind to additional MHC allomorphs
expressed by these macaques.
Fig 5. Assessing the specificity of P12 against a panel of PBMC. PBMC from Mamu-A1*001-positive (top row) and
-negative (bottom three rows) rhesus macaques were stained with P12 (blue traces) or non-specific mouse Ig (red
traces). Cell-bound P12 was detected with FITC-labeled anti-HA antibody and control antibody with FITC-labeled goat
anti-mouse Ig. The MHC haplotypes from which the PBMC were isolated are provided in the upper right corner or each
histogram.
https://doi.org/10.1371/journal.pone.0179039.g005
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Detecting small frequencies of Mamu-A1*001-positive cells
A potential application for an anti-Mamu-A1001 antibody is the specific detection of infre-
quent Mamu-A1001-positive cells among a preponderance of Mamu-A1001-negative cells,
as in detecting chimerisms in macaques after hematopoietic stem cell transplants. To test P12
for this purpose we made artificial mixtures of Mamu-A1001-positive and -negative PBMC.
Five serial 1:3 dilutions of Mamu-A1001-positive cells with Mamu-A1001-negative cells
were stained with P12. We clearly detected the presence of 0.9% (1:81 dilution) and, poten-
tially, 0.5% (1:243 dilution) of Mamu-A1001-positive cells among Mamu-A1001-negative
cells (Fig 6). This result indicates that P12 can be a useful tool for detecting chimerisms or for
isolating infrequent Mamu-A1001-positive cells within a population of Mamu-A1001-nega-
tive cells.
Identifying Mamu-A1*001-positive macaques with P12
Anti-HLA monoclonal antibodies and HLA-sensitized serum were commonly used to HLA
type humans. Therefore, we sought to determine whether P12 could be used to screen for
Mamu-A1001-positive macaques. Blood from two Mamu-A1001-positive and two negative
rhesus macaques were collected and used to develop a screening assay. Since it is more practi-
cal to collect and freeze blood from large cohorts of animals over time for concurrent screen-
ing, we also tested fresh versus frozen whole blood. P12 was incubated with either fresh or
thawed whole blood. Red blood cells in the samples were subsequently lysed and cell-bound
P12 was detected with an anti-HA FITC antibody. P12 bound both fresh and frozen cells from
Mamu-A1001-positive animals but not negative controls (Fig 7). Although we detected simi-
lar results in the fresh and frozen samples the freeze/thaw process negatively affected lympho-
cyte viability. It is, therefore, possible that the freezing process may hinder the ability of P12 to
accurately distinguish Mamu-A1001-positive from -negative macaques. Inclusion of a viabil-
ity dye into the staining design may help in identifying Mamu-A1001-positive macaques, par-
ticularly when using frozen samples.
In order to test whether or not P12 could prospectively distinguish Mamu-A1001-positive
from -negative rhesus macaques we stained frozen blood samples from 48 animals. All animals
were subsequently MHC genotyped, the gold standard for MHC typing, to determine their
MHC haplotypes. P12 identified all of the 15 Mamu-A1001-positive macaques, in complete
concordance with those obtained by MHC genotyping. This indicates that P12 has the poten-
tial to screen animals for Mamu-A1001 by flow cytometry. It is important to note that this
Fig 6. Detection of rare Mamu-A1*001-positive cells among predominantly Mamu-A1*001-negative
cells. Mixtures of serial 1:3 dilutions of Mamu-A1*001-positive PBMC to Mamu-A1*001-negative PBMC
were exposed to P12 and detected with FITC-labeled anti-HA antibody by means of flow cytometry. The
percentages represent the frequencies of Mamu-A1*001-positive lymphocytes detected in each sample.
https://doi.org/10.1371/journal.pone.0179039.g006
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cohort of animals had representatives from 14 Mamu-A and 19 Mamu-B haplotypes without
any apparent cross reactivity by P12.
P12 crossreacts with Mafa-A1*001:01 but not Mafa-A1*001:02/3
allomorphs
P12 effectively binds to Mamu-A1001 but it lacks constant region domains important for
many antibody functions. Additionally, the presence of two anti-Mamu-A1001 Fab on the
same molecule as in natural antibodies, should increase the avidity of the antibody/Mamu-
A1001 interaction. Therefore, to expand the potential utility of the anti-Mamu-A1001 Fab
we reconstituted the complete IgG molecule. As anticipated, the anti-Mamu-A1001 IgG anti-
body only bound cells from Mamu-A1001-positive animals when tested against the same
panel of 12 rhesus macaque PBMC initially used to screen P12 (data not shown).
Cynomolgus macaques are commonly used in infectious disease and transplant research.
Analysis of MHC class I alleles in rhesus and cynomolgus macaques has revealed extensive
sharing of alleles between the two species [43]. Consequently, the cynomolgus macaque MHC
class I allele Mafa-A1001 is a highly related ortholog of Mamu-A1001. We, therefore, deter-
mined if the P12 antibody would bind to Mafa-A1001. Cells from four Mafa-A1001-positive
cynomolgus macaques were stained with the full-length P12 antibody. Unexpectedly, the anti-
body only bound cells from two of the four cynomolgus macaques (Fig 8). We hypothesized
that the discrepancy in antibody binding was due to the expression of different Mafa-A1001
variants among the four macaques. Sequence-based genotyping showed that cells from the ani-
mals to which the P12 antibody bound expressed Mafa-A1001:01, but the other two animals
expressed either the Mafa-A1001:02 or Mafa-A1001:03 variant (the sequence-based genotyp-
ing could not distinguish between these two variants). A maximum of 11 amino acids differ
Fig 7. Detection of Mamu-A1*001-positive animals using whole blood and P12. Fresh or frozen whole
blood from Mamu-A1*001-positive and Mamu-A1*001-negative macaques were stained with P12 (blue
traces) or non-specific mouse Ig (red traces). Red blood cells were lysed, cell-bound P12 was detected with
anti-HA FITC and cell-bound control antibody was detected with anti-mouse Ig FITC. Representative data
from the four animals are shown.
https://doi.org/10.1371/journal.pone.0179039.g007
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between the Mafa-A1-001:01 and the Mafa-A1001:02 (5 amino acids) or Mafa-A1001:03
(11 amino acids) variants. However, four of these 11 amino acid differences shared by the
Mafa–A1001:02/:03 variants are present in the alpha 1 and 2 domains, previously shown to be
critical for MHC allomorph-specific binding of antibodies [44, 45].
Discussion
We report herein the isolation from a phage display library of an antibody that specifically rec-
ognizes the common rhesus macaque MHC class I allomorph Mamu-A1001. The Fab phage
display library was constructed by amplifying immunoglobulin genes from a Mamu-
A1001-negative multiparous female rhesus macaque that had been alloimmunized with cells
from a Mamu-A1001-positive macaque. The phage library was panned using a combination
of MHC monomers and MHC transferent cell lines expressing only a single MHC class I mole-
cule. The isolated anti-Mamu-A1001 Fab bound only to cells expressing Mamu-A1001 and
not to cells expressing other common Indian rhesus macaque MHC class I A or B alleles. We
have reconstituted the complete IgG molecule and it is available to the scientific community
through the Nonhuman Primate Resource Reagent Program.
Monoclonal antibodies are often isolated by immunizing mice with antigens of interest,
making hybridomas by fusing B lymphocytes and myeloma cells, and screening for antigen-
specific antibodies. However, this approach is difficult when isolating monoclonal antibodies
specific for variants of primate polymorphic proteins since mice preferentially target xenoge-
neic framework determinants [10]. We overcame this hurdle by alloimmunizing a rhesus
macaque with PBMC from an MHC disparate macaque to induce MHC allomorph-specific
antibodies. This approach avoided induction of antibodies against common framework epi-
topes due to clonal deletion of self-reactive B cells. To isolate antibodies of interest we created
a phage display library that captured the post-immunization immunoglobulin repertoire. The
library was panned with a combination of MHC monomers and MHC transferents to isolate
an anti-Mamu-A1001-specific antibody. These methods may also be useful in isolating
monoclonal antibodies against other polymorphic host proteins.
Nonhuman primates are genetically more similar to humans than small animal models.
Despite their widespread use, nonhuman primates are potentially underutilized for the pro-
duction and isolation of monoclonal antibodies or antibody fragments. This is in part due to
the cost associated with animal husbandry, housing, and experimental procedures. However,
as we describe here, macaques may provide a valuable resource in isolating antibodies
Fig 8. The P12 antibody differentially binds Mafa-A1*001 variants. PBMC from four cynomolgus
macaques expressing the Mamu-A1*001 ortholog Mafa-A1*001 were stained with PE-labeled P12 antibody
(blue traces) or left unstained (red traces). The P12 antibody only bound cells from animals expressing the
Mafa-A1*001:01 allomorph but not the Mafa-A1*001:02/03 variants. The Mafa-A1*001 allele variant that
each animal expressed is listed above each histogram.
https://doi.org/10.1371/journal.pone.0179039.g008
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targeting polymorphic cellular proteins of nonhuman primate origin. Similar approaches have
previously been used to isolate antibodies from nonhuman primates against therapeutically
relevant infectious disease and human antigens [46]. However, the immunogens in these stud-
ies were infectious agents or purified protein rather than allogeneic cells used in our study.
There are several advantages to using nonhuman primates for isolating monoclonal antibodies
specific for variants of primate polymorphic proteins. First, central tolerance established dur-
ing immune development has eliminated B cells reactive to “self” determinants shared among
polymorphic macaque proteins. Second, alloimmunization allows for affinity maturation and
isolation of high-affinity antibodies. Third, phage-display libraries can be constructed with
cells isolated from the blood or bone marrow, which can be collected without euthanasia and,
thereby, minimizing animal use and preserving a valuable resource.
Indian rhesus macaques are commonly used as models for organ transplantation and infec-
tious diseases. Identifying macaques expressing specific MHC molecules can be an essential
component of experiment design since expression of particular MHC molecules may play an
important role in disease progression and the success or failure of organ transplants [20, 25,
47]. For Indian rhesus macaques, next generation sequencing has become the gold standard
for MHC typing since it can identify all major and minor MHC class I and II alleles. However,
this approach takes specialized equipment and training to execute. The anti-Mamu-A1001
monoclonal antibody, therefore, may be useful to researchers to perform preliminary screens
for Mamu-A1001 positive rhesus macaques. We tested the specificity of the anti-Mamu-
A1001 Fab fragments against panels of whole blood from animals expressing a diverse array
of MHC molecules commonly found in Indian rhesus macaques. We only detected antibody
binding to cells from Mamu-A1001 positive macaques. The screening assay can be performed
by anyone with basic experience with flow cytometry, access to macaque samples, and a flow
cytometer.
Rhesus macaques are used as models for hematopoietic stem cell transplantation. A key
analysis in these studies to assess engraftment or rejection is the measurement of post-trans-
plant chimerism, or the presence of donor cells in the peripheral blood of the graft recipient.
Several PCR-based chimerism assays have been adapted from human clinical assessments for
use in nonhuman primate studies [48–50]. However, these analyses are time consuming and
cannot distinguish between cell populations or lineages without isolating sub-populations
prior to analysis. An alternative approach when MHC-mismatched transplants are performed
is to track chimerism with anti-MHC antibodies by flow cytometry [18, 51]. These techniques
are relatively fast and can be performed in any standard flow cytometry lab to monitor engraft-
ment of different cell subpopulations using anti-MHC antibodies. The anti-Mamu-A1001
antibody that we isolated will be useful in tracking Mamu-A1001-positive cells in Mamu-
A1001-negative rhesus macaques after hematopoietic stem cell transplants. Using an artificial
mixture of cells, we detected a frequency of approximately 1% Mamu-A1001-positive cells in
a population of Mamu-A1001-negative cells. This is comparable to a previous study using a
single anti-HLA antibody to detect chimeric human cells [18, 52]. The isolation of additional
anti-macaque MHC class I antibodies may enhance the detection chimerisms in macaques
and facilitate cell sorting of these populations for further analysis.
In this study, we demonstrate that MHC allomorph-specific monoclonal antibodies can be
isolated from alloimmuninzed rhesus macaques using a phage display technology. The meth-
ods we describe do not require any specialized equipment or technical expertise not already
found in most modern immunology laboratories. Therefore, this approach will likely be
applicable to other model systems attempting to isolate MHC allomorph-specific antibodies.
Additionally, alloimmunization with PBMC or other cell types may be useful for isolating anti-
bodies specific for other polymorphic host proteins.
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